Archaeologists discover long-lost tomb of unknown pharaoh in Egypt
Archaeologists in Egypt recently uncovered a once-in-a-lifetime discovery: an unknown pharaoh's tomb, dating back 3,600 years.
The excavation, which was conducted near the Egyptian city of Abydos this winter, was announced by the Penn Museum in Philadelphia last week. The pharaoh's tomb was found 23 feet underground and featured a decorated entryway and mudbrick vaults.
Pictures show a team of international archaeologists excavating the deep tomb in the Egyptian desert.
Excavation leader Dr. Josef Wegner, an egyptology professor at the University of Pennsylvania, spoke with Fox News Digital about the discovery, which dates back to the Second Intermediate Period.
"Surprisingly, we came upon a royal tomb that we had no idea existed," Wegner said. "Excitingly, it's adding new evidence on what seems to be the early development of a group of fascinating kings that we call the Abydos dynasty. They are kind of a lost, forgotten dynasty."
"There were no human remains remaining, there were no remnants of the king himself or his funerary equipments," he said.
"The original decoration that contained hieroglyphic texts and columns that contained his name had been damaged just enough that the name is gone. But we can see where the name flanked the entrance to his burial chamber."
The excavation wasn't Wegner's first rodeo. In 2014, he discovered a different pharaoh's tomb: Senebkay, another Second Intermediate Period ruler who was totally unknown in the historical record until that time.
"Finding a new pharaoh's tomb is that's always, always quite an exciting moment in time. So it's the second time it's happened to me, and I guess I shouldn't be too greedy, but I'm hoping for more if we can find them," Wegner said.
"He was an unknown king, and we excavated the area right around that. And it seemed like we could more or less exhausted the evidence on this Abydos dynasty…Lo and behold, 10 years almost to the day since finding Senebkay, we found a new tomb that's bigger than any of the other ones," he added.
Wegner, who also works as a curator at the Penn Museum, described the Second Intermediate Period as an "intriguing" part of Egyptian history which spanned from roughly 1650 to 1570 B.C.
"It was a period where Egypt was broken apart into a sort of rival kingdoms," the expert explained. "We think there were as many as four."
"The ancient tomb robbers were not always very considerate in what they did in the process of tomb robbery."
"It provides the basis for the rise and establishment of the new Kingdom of Egypt, which is usually thought of as the golden age of the pharaohs."
Wegner characterized the limestone burial chamber as "grand," complete with mud brick vaults and a "very deep shaft entrance system." But unfortunately, the king's name has not emerged yet.
"We were a little frustrated," Wegner laughed. "The ancient tomb robbers were not always very considerate in what they did in the process of tomb robbery."
"They didn't think about archaeologists in the future that would be looking for bits and pieces of evidence," he added.
"We've completed the full excavation of it and what it was, you know, was essentially robbed out. It seems to have been a very richly-equipped royal tomb. So it did attract tomb robbers for that reason."
Even though the tomb was plundered, Wegner is hopeful that more artifacts will show up in the future – and that the pharaoh's name will be discovered.
"There's significant potential in the orbit of the tomb, around the periphery of it, there could well be objects that were discarded, remains of stone vessels," he described.
"For example, what we call the canopic jars that would have had the name of the king on them. Those kinds of things probably weren't very interesting to tomb robbers."
"And there's indications that there may be more of these tombs," he added.
The next stage is to study the terrain around the tomb, where more evidence is slated to emerge.
The latest discovery comes just weeks after archaeologists found the long-lost tomb of King Thutmose II, which marked the first major royal tomb discovery since King Tutankhamen's tomb was found in 1922.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Archaeologists Uncover 3 Never-Before-Seen Mayan Cities
Archaeologists working in Guatemala's Petén jungle have discovered three ancient Mayan cities, the country's Ministry of Culture and Sports announced in a statement. The cities, arranged in a triangular pattern, rest roughly three miles apart from one another. They were incorporated during a period known as the 'middle preclassic' (1,000-400 B.C.), and remained inhabited until about 1,100 years ago. One site of particular interest to archaeologists, dubbed 'Los Abuelos' or 'the Grandparents,' contains stone sculptures of a man and woman which researchers believe depict the ancestors of the city's citizens. They posit that this site may have served as a ceremonial or religious second newly discovered city, dubbed 'Petnal,' features a 108-foot tall flat-topped pyramid which contains a separate room containing murals. Though most of the artwork has degraded, scientists were able to identify red, white, and black colors; however, further analyses will be required to determine what the murals actually depicted. The third city, Cambrayal, features an intricate series of canals which begin at a water reservoir atop the city's palace. Archaeologists believe these waterways were used for removing waste."It's especially exciting to learn about the Los Abuelos site," Megan O'Neil, an associate professor of art history at Emory University who was not part of the excavation team, told Live Science. O'Neill added that the stonework found at the sites "are especially poignant and are similar to many other examples of Maya people making offerings to vital sculptures and connecting with their ancestors by interacting with sculptures from the past." She believes these recent discoveries will "help reconnect items in private and museum collections with their places of origin and deposition, helping return memory to those ceramics, to these sites, and to Maya people living in this region and across the world."Archaeologists Uncover 3 Never-Before-Seen Mayan Cities first appeared on Men's Journal on Jun 9, 2025
Yahoo
2 days ago
- Yahoo
AI Program Rewrites Timeline of Dead Sea Scrolls
A newly developed AI model has allowed researchers to re-date many of the Dead Sea Scrolls, some of which now appear to be much older than previously thought. The University of Groningen announced the news in a June 4 press release. The Dead Sea Scrolls were discovered between 1947 and 1956 in the Caves of Qumran, and in the decades since have recontextualized modern understandings of ancient Jewish practices as well as the Bible. Accurately dating the manuscripts is vital to understanding their influence, as well as the time at which they were AI model, known as Enoch, combined carbon-14 dating from 24 separate samples of Dead Sea Scrolls with an AI-driven handwriting analysis to examine micro-level ink-trace patterns on the scrolls. The model then compares known handwriting features with known radiocarbon dates, allowing the AI to understand how handwriting styles evolved throughout time. The AI model can predict the creation date of a given manuscript within 30 years, researchers results astounded scientists. Some scrolls, which were thought to have originated in the Hasmonaean period (150-50 B.C.) are now believed to be from several centuries earlier. Likewise, the Herodian script, which was believed to have been written in the mid-first century B.C., now appears to have been authored in the late second century B.C. "Enoch is the first complete machine-learning-based model that uses raw image inputs to produce probabilistic date predictions for ancient manuscripts," said Maruf Dali, the research team leader. They hope the technology can add similar context to other ancient manuscripts, which might help to understand the political and religious climates of the Program Rewrites Timeline of Dead Sea Scrolls first appeared on Men's Journal on Jun 7, 2025
Yahoo
3 days ago
- Yahoo
Common menopause medication might prevent breast cancer while treating hot flashes
A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, "significantly reduced" breast tissue cell growth, which is a major indicator of cancer progression. A phase 2 clinical trial included 141 post-menopausal women who had been diagnosed with ductal carcinoma in situ (DCIS), also known as stage 0 breast cancer, according to a press release from Northwestern. Prostate Cancer Drug Now Available To More Patients With Aggressive Form Of Disease This non-invasive breast cancer affects more than 60,000 American women each year, often leading to an outcome of invasive breast cancer. The women were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Read On The Fox News App Duavee is a conjugated estrogen/bazedoxifene (CE/BZA) drug, which combines estrogen with another medication that minimizes the potential harmful side effects of the hormone. "The key takeaway from the study is that CE/BZA slows the growth (proliferation) of cells in milk ducts of DCIS that expressed the estrogen receptor significantly more than placebo," Dr. Swati Kulkarni, lead investigator and professor of breast surgery at Northwestern University Feinberg School of Medicine, told Fox News Digital. Experimental Women's Cancer Drug Boosts Survival Rates In Notable Study Another major finding is that the quality of life did not differ significantly between the two groups, but patients who took the CE/BZA reported fewer hot flashes during the study, she noted. "This would be expected, as the drug is FDA-approved to treat hot flashes." Kulkarni presented the study last week at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. The findings are preliminary and have not yet been published in a medical journal. "What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer," said the doctor, who is also a Northwestern Medicine breast surgeon. Women who face a higher risk of breast cancer — including those who have experienced "high-risk lesions" — and who also have menopausal symptoms are most likely to benefit from the drug, according to Kulkarni. "These women are typically advised against standard hormone therapies, leaving them with few menopausal treatment options," the release stated. The researchers said they are "encouraged" by these early results, but more research is required before the medication can be considered for approval as a breast cancer prevention mechanism. "Our findings suggest that CE/BZA may prevent breast cancer, but larger studies with several years of follow-up are needed before we would know this for sure," Kulkarni told Fox News Digital. Dr. Sheheryar Kabraji, chief of breast medicine at the Roswell Park Comprehensive Cancer Center in Buffalo, New York, was not involved in the study but commented on the findings. "While intriguing, this study is highly preliminary, and more research will be needed before we can conclude that conjugated estrogen/bazedoxifene (CD/BZA), a form of the hormone estrogen commonly prescribed to address symptoms of menopause, prevents invasive breast cancer or is effective at reducing cancer risk," she told Fox News Digital. Click Here To Sign Up For Our Health Newsletter Kabraji also noted that the study focused on reducing levels of one specific protein, "which does not always predict reduced recurrence of breast cancer." "This study did not directly show that CE/BZA treatment reduces the risk of DCIS recurrence or development of invasive cancer," she noted. "Importantly, however, patients who received this therapy experienced no worsening of quality of life, and saw improvement in vasomotor symptoms, such as hot flashes. If found to be effective in preventing breast cancer, CE/BZA is likely to have fewer side effects than current medications used for breast cancer prevention." For more Health articles, visit Lead researcher Kulkarni emphasized that this medication is not for the treatment of invasive breast cancer or DCIS. "Right now, we can say that women who are concerned about their risk of developing breast cancer can consider this medication to treat their menopausal symptoms," she article source: Common menopause medication might prevent breast cancer while treating hot flashes
